Translational Neurodegeneration

Zhentao Zhang et al.

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Naomi P. Visanji, et al.

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Articles

Recent

Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation

Authors: Luodan Yang, Hannah Youngblood, Chongyun Wu and Quanguang Zhang

Content type: Review

1 June 2020
The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline

Authors: Haifeng Chen, Xiaoning Sheng, Caimei Luo, Ruomeng Qin, Qing Ye, Hui Zhao, Yun Xu and Feng Bai

Content type: Research

27 May 2020
Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: a meta-analytic review on potential mechanisms

Authors: Chuan Qin, Yalan Lu, Kewei Wang, Lin Bai, Guiying Shi, Yiying Huang and Yongning Li

Content type: Review

27 May 2020
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Authors: Peng-Hui Ai, Si Chen, Xian-Dong Liu, Xiao-Na Zhu, Yuan-Bo Pan, Dong-Fu Feng, Shengdi Chen, Nan-Jie Xu and Suya Sun

Content type: Research

12 May 2020
The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases

Authors: Qiaoyun Song, Bo Meng, Haidong Xu and Zixu Mao

Content type: Review

11 May 2020

Most recent articles RSS

View all articles

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Announcing the launch of In Review

Translational Neurodegeneration, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

Share their work with fellow researchers to read, comment on, and cite even before publication
Showcase their work to funders and others with a citable DOI while it is still under review
Track their manuscript - including seeing when reviewers are invited, and when reports are received

See the full range of benefits of In Review and how to opt-in

See what the In Review platform looks like

Translational Neurodegeneration

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Articles

Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation

The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline

Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: a meta-analytic review on potential mechanisms

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases

Editor-in-Chief

Aims and Scope

Announcing the launch of In Review

Affiliated with

Annual Journal Metrics

Translational Neurodegeneration

Contact us